Prophylactic antilymphocyte globulin and HLA-DR matching reduce the incidence of rejection after cadaveric kidney transplantation.
Weimar
W
W
Department of Internal Medicine, University Hospital Rotterdam-Dijkzigt, The Netherlands.
Hendriks
G F
GF
Wenting
G J
GJ
Vincent
H H
HH
Schreuder
G M
GM
Jeekel
J
J
D058186:Acute Kidney Injury / Q000517:prevention & control; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D006084:Graft Rejection; D006681:HLA-D Antigens / Q000032:analysis*; D006684:HLA-DR Antigens / Q000032:analysis*; D006801:Humans; D007165:Immunosuppression Therapy; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation
D000961:Antilymphocyte Serum; D006681:HLA-D Antigens; D006684:HLA-DR Antigens